From the Patent Universe

This is a real patent from the public record — curated here so you can explore, research, and analyze real-world IP. It's not currently listed for sale. Own it? Claim it →

softwareSale & License🛒 Fixed Sale 0 views

CRISPR-Cas Gene Editing Delivery Vector for Targeted Neural Tissue Therapeutic Intervention

Patent #US11999402B2

Public record:Verify on Google Patents

A synthetic viral vector designed for site-specific delivery of genetic editing components into central nervous system tissues. The invention allows for enhanced blood-brain barrier penetration without inducing adverse immune responses.

Issue Date

5/1/2026

Inventor

Dr. Sarah Jenkins

Seller Location

United States

Price on request

Real Patent · Not Yet Listed

This patent is showcased from the public record so you can explore real IP. It's not currently for sale — but there are two ways to change that.

Need help with this transaction?

Our team at RocketPatentMe can assist with due diligence, transfer agreements, and legal paperwork.